We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.8B
AUM Growth
+$1.43B
(+8.8%)
Cap. Flow
+$2.47B
Cap. Flow
% of AUM
13.89%
Top 10 Holdings %
Top 10 Hldgs %
2.97%
Holding
5,084
New
749
Increased
1,923
Reduced
1,590
Closed
686
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$70.4M |
| 2 |
Charter Communications
CHTR
|
+$62M |
| 3 |
Costco
COST
|
+$48.5M |
| 4 |
CME Group
CME
|
+$44.7M |
| 5 |
Coca-Cola
KO
|
+$36.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$55.4M |
| 2 |
Netflix
NFLX
|
+$48.9M |
| 3 |
Archer Daniels Midland
ADM
|
+$41.4M |
| 4 |
Workday
WDAY
|
+$40.1M |
| 5 |
NXP Semiconductors
NXPI
|
+$39.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.69% |
| 2 | Technology | 13.52% |
| 3 | Healthcare | 9.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRHC
4101
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $63K | ﹤0.01% |
13,104
-31,201
| -70% | -$134K |
|
4102
Lands' End
LE
$402M
| $62K | ﹤0.01% |
8,086
+7,195
| +808% | +$88.5K |
|
|
NEWP
4103
New Pacific Metals
NEWP
$1.16B
| $61K | ﹤0.01% |
+29,000
| New | +$77K |
|
4104
Companhia Siderúrgica Nacional
SID
$1.19B
| $61K | ﹤0.01% |
+25,722
| New | +$71K |
|
|
TIGR
4105
UP Fintech Holding
TIGR
$877M
| $61K | ﹤0.01% |
+18,500
| New | +$70.6K |
|
4106
Clear Channel Outdoor Holdings
CCO
$1.23B
| $60K | ﹤0.01% |
44,000
-60,900
| -58% | -$92.1K |
|
4107
Mizuho Financial
MFG
$127B
| $60K | ﹤0.01% |
+27,114
| New | +$63K |
|
|
TPC
4108
Tutor Perini Cor
TPC
$5.18B
| $59K | ﹤0.01% |
10,767
-233
| -2% | -$1.77K |
|
4109
Apyx Medical
APYX
$146M
| $58K | ﹤0.01% |
12,814
+437
| +4% | +$3.13K |
|
4110
Puma Biotechnology
PBYI
$449M
| $57K | ﹤0.01% |
24,136
-45,802
| -65% | -$134K |
|
4111
ADC Therapeutics
ADCT
$144M
| $56K | ﹤0.01% |
+11,519
| New | +$83.4K |
|
|
FYBR
4112
DELISTED
Frontier Communications
FYBR
| $56K | ﹤0.01% |
2,400
-52,125
| -96% | -$1.33M |
|
4113
Full House Resorts
FLL
$90.5M
| $55K | ﹤0.01% |
+9,740
| New | +$62.8K |
|
4114
Lexicon Pharmaceuticals
LXRX
$1.07B
| $55K | ﹤0.01% |
+22,845
| New | +$63.2K |
|
|
JOYY
4115
JOYY Inc
JOYY
$3.77B
| $55K | ﹤0.01% |
2,100
-11,979
| -85% | -$329K |
|
|
PSTX
4116
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $55K | ﹤0.01% |
+15,510
| New | +$51.3K |
|
4117
Accuray
ARAY
$34.9M
| $54K | ﹤0.01% |
25,753
-377,922
| -94% | -$859K |
|
4118
Tiptree Inc
TIPT
$673M
| $54K | ﹤0.01% |
5,021
-903
| -15% | -$10.3K |
|
4119
Kopin
KOPN
$780M
| $53K | ﹤0.01% |
50,259
-45,709
| -48% | -$63.9K |
|
4120
Vera Bradley
VRA
$96.4M
| $53K | ﹤0.01% |
17,731
-71,626
| -80% | -$288K |
|
|
QCLS
4121
Q/C Technologies Inc
QCLS
$22.1M
| $53K | ﹤0.01% |
+7
| New | +$77K |
|
|
OMIC
4122
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $53K | ﹤0.01% |
701
-506
| -42% | -$52.9K |
|
|
LGVCW
4123
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
| $53K | ﹤0.01% |
533,773
| – | – |
|
|
ORLA
4124
DELISTED
Orla Mining
ORLA
| $52K | ﹤0.01% |
+15,800
| New | +$48.5K |
|
4125
Verastem
VSTM
$615M
| $52K | ﹤0.01% |
5,067
-16,106
| -76% | -$225K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q3 2022 Portfolio in Review
As of Q3 2022, Cubist Systematic Strategies held 5,084 positions worth $17.8B, up 8.8% from $16.4B the previous quarter. Its ten largest holdings account for 3% of the portfolio.
Cubist Systematic Strategies deployed $2.47B of net new capital in Q3 2022, opening 749 new positions and adding to 1,923 existing holdings. Its largest new stake was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of America, an estimated $55.4M trimmed.
- Cubist Systematic Strategies's largest Q3 2022 buy was Global Blockchain Acquisition Corp. Common Stock: 845,248 shares worth $8.34M.
- Cubist Systematic Strategies added most to Visa in Q3 2022, an estimated $70.4M increase.
- Cubist Systematic Strategies's biggest Q3 2022 reduction was Bank of America, cutting an estimated $55.4M.
- Cubist Systematic Strategies fully exited Bristol-Myers Squibb in Q3 2022, selling an estimated $24.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3% of its $17.8B portfolio in Q3 2022.
- Cubist Systematic Strategies opened 749 new positions and closed 686 in Q3 2022.
- Cubist Systematic Strategies's portfolio value rose 8.8% quarter-over-quarter to $17.8B.
Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.